Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3735021
Max Phase: Preclinical
Molecular Formula: C35H53N7O6
Molecular Weight: 667.85
Molecule Type: Small molecule
Associated Items:
ID: ALA3735021
Max Phase: Preclinical
Molecular Formula: C35H53N7O6
Molecular Weight: 667.85
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)C(C)C)[C@@H](O)CC(=O)NCCc1ccccc1
Standard InChI: InChI=1S/C35H53N7O6/c1-23(2)20-28(29(43)21-30(44)38-19-17-25-12-7-5-8-13-25)40-33(46)31(24(3)4)42-32(45)27(16-11-18-39-34(36)37)41-35(47)48-22-26-14-9-6-10-15-26/h5-10,12-15,23-24,27-29,31,43H,11,16-22H2,1-4H3,(H,38,44)(H,40,46)(H,41,47)(H,42,45)(H4,36,37,39)/t27-,28-,29-,31-/m0/s1
Standard InChI Key: DSPSRDPXLLWIRH-KECWCRPSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 667.85 | Molecular Weight (Monoisotopic): 667.4057 | AlogP: 2.33 | #Rotatable Bonds: 20 |
Polar Surface Area: 207.76 | Molecular Species: BASE | HBA: 7 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.44 | CX Basic pKa: 11.81 | CX LogP: 2.31 | CX LogD: 0.22 |
Aromatic Rings: 2 | Heavy Atoms: 48 | QED Weighted: 0.06 | Np Likeness Score: 0.22 |
1. Gazdik M, O'Neill MT, Lopaticki S, Lowes KN, Smith BJ, Cowman AF, Boddey JA, Sleebs BE. (2015) The effect of N-methylation on transition state mimetic inhibitors of the Plasmodium protease, plasmepsin V, 6 (3): [10.1039/C4MD00409D] |
Source(1):